Studies have confirmed that AgNPs increase the caspase-3 level in breast cancer [39], lung cancer [40]  and other cancers, indicating that tAgNP-treated OC cells complete the apoptosis process through the cysteine protease pathway. The gene discussed is CASP3; the disease is lung carcinoma.